Niagen Bioscience Strengthens IP Moat with New Patent for NAD+ IV and Injectable Formulations
Patent Expands Niagen’s Leadership in NAD+ Delivery, Supporting Faster and Safer Treatments Why is the race for intellectual property in the NAD+ market heating up? Niagen Bioscience, Inc. a global…
Atlanta Hawks and Ressler Gertz Family Foundation Donate $150,000 to Prostate Cancer Research
Hawks and Ressler Gertz Family Foundation Boost Prostate Cancer Research with $150,000 Donation Why is prostate cancer awareness and research crucial in the sports industry? The Atlanta Hawks Foundation, in…
Alpha Cognition Enrolls First Patient in BEACON Study for ZUNVEYL
Real-World Impact of ZUNVEYL in Long-Term Care to Be Assessed What does the future hold for Alzheimer’s disease treatment in long-term care settings? Alpha Cognition Inc. a biopharmaceutical company focused…
NYU Abu Dhabi and RTW Investments Partner to Advance Healthcare Innovation in the Middle East
Strategic Collaboration to Convene Global Investors and Leaders for Healthcare Advancement Why is the Middle East emerging as a critical hub for healthcare innovation? NYU Abu Dhabi and RTW Investments,…
Asahi Kasei Pharma Strengthens Drug Discovery Pipeline with Alchemedicine
Strategic License Agreement Advances Novel Compounds for Autoimmune Diseases Why are autoimmune diseases still a significant challenge for pharmaceutical companies? Asahi Kasei Pharma, a global leader in drug development, is…
Chemify and Sanacor Partner to Accelerate Mitochondrial Dysfunction Therapies
Chemify and Sanacor Join Forces to Tackle Diabetic Cardiovascular Disease Why is the discovery of new therapies for diabetic cardiovascular disease so critical? Chemify, a deep-tech pioneer in Chemputation, and…
Enveric Biosciences Secures Patent Protection Amidst Industry Challenges
Enveric Biosciences Overcomes Legal Hurdles to Protect Innovative Neuroplastogenic Therapeutics What does the withdrawal of a patent challenge mean for a biotech company’s intellectual property and future innovations? Enveric Biosciences…
Kivu Bioscience Advances KIVU-305 into Clinical Trials for CEACAM5-Expressing Cancers
Kivu Bioscience Secures HREC Approval and CTN Clearance for Next-Generation ADC Why are next-generation antibody-drug conjugates (ADCs) crucial for advancing cancer treatments? Kivu Bioscience, a clinical-stage biotechnology company based in…
Ironwood Pharmaceuticals Reports Strong 2025 Financials and Advances Apraglutide for SBS-IF
Ironwood Strengthens LINZESS Market Leadership and Prepares for Apraglutide Phase 3 Trials Why are biotechnology companies like Ironwood Pharmaceuticals crucial in addressing unmet needs in gastrointestinal diseases? Ironwood Pharmaceuticals, a…
Ionis Pharmaceuticals Reports Strong 2025 Financials and Pipeline Progress
Ionis Poised for Continued Growth with Multiple Upcoming Therapeutic Launches Is the biotech industry ready for a new wave of transformative therapies? Ionis Pharmaceuticals, a leader in RNA-targeted therapies, reported…
IQVIA Acquires Charles River Laboratories’ Discovery Services to Enhance Drug Discovery Capabilities
IQVIA Strengthens Early-Stage Discovery Research with Advanced In Vitro and AI-Driven Solutions Why is the life sciences industry facing a critical need for accelerated drug discovery? IQVIA Holdings Inc. a…
BreezeBio Secures $60M Series B to Advance Genetic Medicines for Autoimmune Diseases
Funding Boosts Development of NanoGalaxy Platform and Lead Candidate BRZ-101 for Type 1 Diabetes Why is targeted gene delivery a critical challenge in the biotech industry? BreezeBio, a biotechnology company…